-
Symbol
-
TLSI on Nasdaq
-
Investment type
-
Equity / Common stock, $0.0001 par value
-
Latest Disclosed Ownership
-
2.99M shares
-
Security Ownership
-
6%
Mats Wahlstrom ownership in TriSalus Life Sciences, Inc. Common stock, $0.0001 par value (TLSI)
2025-08-01 - Mats Wahlstrom has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 2.99M shares of TriSalus Life Sciences, Inc. Common stock, $0.0001 par value (TLSI).
This represents 6% percent ownership of the company.
In their previous filing dated 2024-12-19, Wahlstrom Mats had reported owning 2.8M shares, indicating an increase of 6.81% percent.